214680 — DR tech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for DR tech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	70,277	89,481	92,439	97,559	116,304
Cost of Revenue
Gross Profit	31,874	40,306	42,348	39,512	41,981
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	67,481	84,566	92,330	109,665	131,614
Operating Profit	2,796	4,915	109	-12,105	-15,310
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,903	5,227	-852	-18,761	-25,691
Provision for Income Taxes
Net Income After Taxes	3,953	5,950	-2,062	-19,291	-24,029
Minority Interest
Net Income Before Extraordinary Items
Net Income	4,038	5,972	-2,248	-19,290	-24,027
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	4,085	5,986	-2,248	-19,290	-24,027
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	51.6	94.7	-37.6	-262	-309
Dividends per Share